Literature DB >> 32404234

Outbreaks of Typhlocolitis Caused by Hypervirulent Group ST1 Clostridioides difficile in Highly Immunocompromised Strains of Mice.

Kathleen G L Ma1, Kvin Lertpiriyapong2, Alessandra Piersigilli3, Irina Dobtsis4, Juliette R K Wipf3, Eric R Littmann5, Ingrid Leiner5, Eric G Pamer5, Rodolfo J Ricart Arbona2, Neil S Lipman6.   

Abstract

Clostridioides difficile is an enteric pathogen that can cause significant clinical disease in both humans and animals. However, clinical disease arises most commonly after treatment with broad-spectrum antibiotics. The organism's ability to cause naturally occurring disease in mice is rare, and little is known about its clinical significance in highly immunocompromised mice. We report on 2 outbreaks of diarrhea associated with C. difficile in mice. In outbreak 1, 182 of approximately 2, 400 NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) and related strains of mice became clinically ill after cessation of a 14-d course of 0.12% amoxicillin feed to control an increase in clinical signs associated with Corynebacterium bovis infection. Most mice had been engrafted with human tumors; the remainder were experimentally naïve. Affected animals exhibited 1 of 3 clinical syndromes: 1) peracute death; 2) severe diarrhea leading to euthanasia or death; or 3) mild to moderate diarrhea followed by recovery. A given cage could contain both affected and unaffected mice. Outbreak 2 involved a small breeding colony (approximately 50 mice) of NOD. CB17-Prkdcscid/NCrCrl (NOD-scid) mice that had not received antibiotics or experimental manipulations. In both outbreaks, C. difficile was isolated, and toxins A and B were detected in intestinal content or feces. Histopathologic lesions highly suggestive of C. difficile enterotoxemia included fibrinonecrotizing and neutrophilic typhlocolitis with characteristic 'volcano' erosions or pseudomembrane formation. Genomic analysis of 4 isolates (3 from outbreak 1 and 1 from outbreak 2) revealed that these isolates were closely related to a pathogenic human isolate, CD 196. To our knowledge, this report is the first to describe naturally occurring outbreaks of C. difficile-associated typhlocolitis with significant morbidity and mortality in highly immunocompromised strains of mice.

Entities:  

Year:  2020        PMID: 32404234      PMCID: PMC7287380          DOI: 10.30802/AALAS-CM-19-000109

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  78 in total

1.  Body condition scoring: a rapid and accurate method for assessing health status in mice.

Authors:  M H Ullman-Culleré; C J Foltz
Journal:  Lab Anim Sci       Date:  1999-06

2.  Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)?

Authors:  C E Berry; K A Davies; D W Owens; M H Wilcox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-05       Impact factor: 3.267

3.  Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

Authors:  Eero Mattila; Raija Uusitalo-Seppälä; Maarit Wuorela; Laura Lehtola; Heimo Nurmi; Matti Ristikankare; Veikko Moilanen; Kimmo Salminen; Maaria Seppälä; Petri S Mattila; Veli-Jukka Anttila; Perttu Arkkila
Journal:  Gastroenterology       Date:  2011-12-07       Impact factor: 22.682

4.  A mouse model of Clostridium difficile-associated disease.

Authors:  Xinhua Chen; Kianoosh Katchar; Jeffrey D Goldsmith; Nanda Nanthakumar; Adam Cheknis; Dale N Gerding; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2008-09-10       Impact factor: 22.682

Review 5.  Non-human C. difficile Reservoirs and Sources: Animals, Food, Environment.

Authors:  Cristina Rodriguez Diaz; Christian Seyboldt; Maja Rupnik
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

6.  Risk estimation for recurrent Clostridium difficile infection based on clinical factors.

Authors:  Ralph B D'Agostino; Sylva H Collins; Karol M Pencina; Yin Kean; Sherwood Gorbach
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079

7.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Authors:  Katharina Brandl; George Plitas; Coralia N Mihu; Carles Ubeda; Ting Jia; Martin Fleisher; Bernd Schnabl; Ronald P DeMatteo; Eric G Pamer
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

Review 8.  Clostridioides difficile therapeutics: guidelines and beyond.

Authors:  Robert Orenstein; Roberto L Patron
Journal:  Ther Adv Infect Dis       Date:  2019-08-13

9.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

10.  Host-Microbiota Interactions in the Pathogenesis of Antibiotic-Associated Diseases.

Authors:  Joshua S Lichtman; Jessica A Ferreyra; Katharine M Ng; Samuel A Smits; Justin L Sonnenburg; Joshua E Elias
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

View more
  1 in total

1.  Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents.

Authors:  Anna C Fagre; Uma Pugazhenthi; Christopher Cheleuitte-Nieves; Marcus J Crim; Kenneth S Henderson; Derek L Fong; Jori K Leszczynski; Michael J Schurr; Joshua B Daniels; Christopher A Manuel
Journal:  Comp Med       Date:  2021-04-08       Impact factor: 0.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.